Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Miscellaneous

Miscellaneous
I/II
Mohan, Sanjay
NCT04455841
VICCHEMP2051

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: